New Concepts In White Adipose Tissue Physiology.

Numerous studies address the physiology of adipose tissue (AT). The interest surrounding the physiology of AT is primarily the result of the epidemic outburst of obesity in various contemporary societies. Briefly, the two primary metabolic activities of white AT include lipogenesis and lipolysis. Throughout the last two decades, a new model of AT physiology has emerged. Although AT was considered to be primarily an abundant energy source, it is currently considered to be a prolific producer of biologically active substances, and, consequently, is now recognized as an endocrine organ. In addition to leptin, other biologically active substances secreted by AT, generally classified as cytokines, include adiponectin, interleukin-6, tumor necrosis factor-alpha, resistin, vaspin, visfatin, and many others now collectively referred to as adipokines. The secretion of such biologically active substances by AT indicates its importance as a metabolic regulator. Cell turnover of AT has also recently been investigated in terms of its biological role in adipogenesis. Consequently, the objective of this review is to provide a comprehensive critical review of the current literature concerning the metabolic (lipolysis, lipogenesis) and endocrine actions of AT.47192-20

Pharmacological blockers of the renin-angiotensin system and the regulation of the metabolism in isolated fat cells.

Dados recentes apontam para a participação do sistema renina-angiotensina (SRA) em processos metabólicos, devido a sua presença local em tecidos metabolicamente ativos, como o tecido adiposo, e sugerem que tais tecidos também poderiam ser alvos dos bloqueadores do SRA. Por isso, investigamos possíveis efeitos diretos de bloqueadores do SRA no metabolismo celular de adipócitos isolados. Para isso, adipócitos isolados foram tratados com doses não tóxicas de Alisquireno ou Captopril ou Losartan. Após 24 horas, as capacidades lipolíticas, lipogênicas e oxidativas foram. Como resultados, o fármaco Alisquireno, aumentou a relação entre oxidação de glicose e incorporação desse substrato em lipídeos, enquanto o Captopril diminuiu a incorporação de glicose em lipídeos, particularmente na fração glicerol do TAG mediante estímulo com insulina, bem como diminuiu a expressão gênica de receptor de (pró) renina. Como conclusão, os fármacos Captopril e Alisquireno podem modular o metabolismo lipogênico e oxidativo de adipócitos isolados, mas de maneiras diferentes.Recent data indicate a participation of the renina-angiotensin system (RAS) in metabolic process, due its local presence in tissues, like the adipose tissue, and suggests that these tissues could be targets of RAS blockers. Therefore, we have studied the possible effects of pharmacological RAS blockers in isolated fat cells. Therefore, fat cells were isolated of epididymal fat pad and treated with non toxic doses of Aliskiren or Captopril or Losartan. After 24 hours, the lipolytic, lipogenic and oxidative capacity were tested in their respective spontaneous and stimulated states. Also, gene expression of PPARg and RAS components were verified. The results showed Aliskiren increases the relation between oxidation and lipogenesis from glucose, whereas Captopril decreased glucose lipid incorporation, especially in glicerol fraction of triglyceride when insulin stimulus exist, and the Renin receptor gene expression. As a conclusion, Captopril and Aliskiren can directly modulate lipogenic and oxidative metabolism of isolated fat cells, but in a different way

Physiological concentrations of ketone bodies do not induce browning of white adipocytes/adipose tissue: in vitro and in vivo studies.

Em animais, dietas cetogênicas induzem o Browning de tecidos adiposos brancos, fenômeno caracterizado pelo de aumento de adipócitos capazes de expressar a proteína desacopladora 1 (UCP1) e outros marcadores de gordura marrom em meio a gordura branca. Estudo anterior demonstrou que o β-hidroxibutirato (βHB), principal corpo cetônico, aumenta marcadores do processo de browning em adipócitos brancos (in vitro) após 24 horas de incubação. No entanto, as doses testadas foram suprafisiológicas (50 mM) ou apenas encontradas durante a cetoacidose (25 mM). As dietas cetogênicas aumentam a cetonemia em torno de 1-3 mM. O jejum prolongado pode aumentá-lo para 4-7 mM. Uma vez que poderia ser provocada in vivo através de intervenções dietéticas, estudamos o impacto de concentrações fisiológicas de βHB no metabolismo e marcadores de Browning em adipócitos brancos / tecido adiposo em diferentes modelos: adipócitos isolados de ratos Wistar, células 3T3 -L1 e in vivo, através da suplementação de sais de βHB em ratos Wistar. Demostramos que o βHB: não induz o aparecimento diferentes marcadores de Browning (tais como o incremento: da capacidade oxidativa, da atividade de citrato sintase e de genes relacionados ao Browning) em adipócitos isolados após 24 ou 48 horas de tratamento; não exerce efeito permissivo no browning induzido por agonismo β-adrenérgico. Além disso, os adipócitos 3T3-L1 diferenciados com βHB (4mM) tiveram diminuição de 52% na expressão de Ucp1, resultado que foi reproduzido no tecido adiposo inguinal subcutâneo de ratos Wistar após a ingestão de sais DL- βHB, onde a expressão gênica de Ucp1 foi indetectável. Em conclusão, embora as causas de browning do tecido adiposo branco induzido por dietas cetogênicas permaneçam inconclusivas, nosso estudo demonstra a incapacidade de, em concentrações fisiológicas, os corpos cetônicos serem, por si, responsáveis por esse fenômeno. Pelo contrário, em algumas situações, o βHB pode prejudicar a expressão da Ucp1.In animals, ketogenic diets induce browning of white adipose tissue, a phenomenon characterized by the increase of adipocytes capable of expressing the uncoupling protein 1 (UCP1) and other markers of brown fat in among white fat. A previous study demonstrated that β-hydroxybutyrate (βHB), the major ketone body, increases markers of the browning process in white adipocytes (in vitro) after 24 hours of incubation. However, the doses tested were supraphysiological (50 mM) or only found during ketoacidosis (25 mM). Ketogenic diets increase ketonemia by about 1-3 mM. Prolonged fasting can increase it to 4-7 mM. Since it could be elicited in vivo through dietary interventions, we studied the impact of physiological concentrations of βHB on metabolism and browning markers on white adipocytes/adipose tissue in different models: adipocytes isolated from Wistar rats, 3T3-L1 cells and in vivo, through the supplementation of βHB salts in Wistar rats. We demonstrate that βHB does not increase any browning markers (such as: oxidative capacity, citrate synthase activity, and browning related genes expression) in isolated adipocytes after 24 or 48 hours of treatment; does not exert a permissive effect on browning induced by β-adrenergic agonism. In addition, 3T3-L1 adipocytes differentiated with βHB (4mM) had a 52% decrease in Ucp1 expression, a result that was reproduced in the subcutaneous inguinal adipose tissue of Wistar rats after ingestion of DL-βHB salts, where Ucp1 expression was undetectable. In conclusion, although the causes of browning of white adipose tissue during ketogenic diets remain inconclusive, our study demonstrates the inability, in physiological concentrations, of ketone bodies themselves to be responsible for this phenomenon. In contrast, in some situations, βHB may impair the expression of Ucp1

Impaired glucose tolerance in low-carbohydrate diet: maybe only a physiological state

Conselho Nacional de Desenvolvimento da Pesquisa (National Council of Research Development) - 476148/2010-3Fundação de Amparo à Pesquisa do Estado de Sao Paulo (Sao Paulo State Research Foundation) - 10/00246-

Renin-angiotensin system blockers regulate the metabolism of isolated fat cells in vitro

Due to the presence of the renin-angiotensin system (RAS) in tissues and its specific influence on white adipose tissue, fat cells are possible targets of pharmacological RAS blockers commonly used as anti-hypertensive drugs. In the present study, we investigated the effects of different RAS blockers on fat cell metabolism, more specifically on lipolysis, lipogenesis and oxidation of energy substrates. Isolated primary adipocytes were incubated with different RAS blockers (aliskiren, captopril and losartan) in vitro for 24 h and lipolysis, lipogenesis and glucose oxidation capacities were determined in dose-response assays to a β-adrenergic agonist and to insulin. Although no change was found in lipolytic capacity, the RAS blockers modulated lipogenesis and glucose oxidation in a different way. While captopril decreased insulin-stimulated lipogenesis (−19% of maximal response and −60% of insulin responsiveness) due to reduced glucose derived glycerol synthesis (−19% of maximal response and 64% of insulin responsiveness), aliskiren increased insulin-stimulated glucose oxidation (+49% of maximal response and +292% of insulin responsiveness) in fat cells. Our experiments demonstrate that RAS blockers can differentially induce metabolic alterations in adipocyte metabolism, characterized by a reduction in lipogenic responsiveness or an increase in glucose oxidation. The impact of RAS blockers on adipocyte metabolism may have beneficial implications on metabolic disorders during their therapeutic use in hypertensive patients

New concepts in white adipose tissue physiology

Numerous studies address the physiology of adipose tissue (AT). The interest surrounding the physiology of AT is primarily the result of the epidemic outburst of obesity in various contemporary societies. Briefly, the two primary metabolic activities of white AT include lipogenesis and lipolysis. Throughout the last two decades, a new model of AT physiology has emerged. Although AT was considered to be primarily an abundant energy source, it is currently considered to be a prolific producer of biologically active substances, and, consequently, is now recognized as an endocrine organ. In addition to leptin, other biologically active substances secreted by AT, generally classified as cytokines, include adiponectin, interleukin-6, tumor necrosis factor-alpha, resistin, vaspin, visfatin, and many others now collectively referred to as adipokines. The secretion of such biologically active substances by AT indicates its importance as a metabolic regulator. Cell turnover of AT has also recently been investigated in terms of its biological role in adipogenesis. Consequently, the objective of this review is to provide a comprehensive critical review of the current literature concerning the metabolic (lipolysis, lipogenesis) and endocrine actions of AT

Atkins diet program rapidly decreases atherogenic index of plasma in trained adapted overweight men

Background The Atkins diet program is a great example of the application of low carbohydrate diets for obesity, with the intention of weight loss and improvement in cardiovascular risk (CV risk). A good CV risk predictor is the atherogenic index of plasma (AIP) calculated as log (TG/HDL [mmol]), which is strongly affected by serum triglycerides, which in turn is associated with the carbohydrate intake. This study determined the effect of the initial phase of Atkins diet program, consisting in 20 g/day of carbohydrate intake with positive urinary ketones measure, in AIP of 12 adult overweight trained adapted men. The AIP was calculated before and after intervention. Results After 14 days, BMI and triglycerides decreased significantly, while HDL-C increased. No alterations were described in LDL plasmatic concentration. Prior to the diet, 58.3% of subjects presented high CV risk and after 14 days of the diet program only 33.3% of subjects were classified as high CV risk, while more than 66% were low CV risk. The intervention was effective in 11 of 12 participants. However, in one person the dietary intervention increased AIP index. Conclusion The initial phase of Atkins diet program could significantly decrease the AIP in 11 of 12 adult overweight trained adapted men. Dietary individual responses need to be more studied